Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

84

Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

Tags:

Previous Article

ALS drug effectively treats Alzheimer’s disease

Inhibition of ceramide synthesis contributes to cardiometabolic diseases

Related Posts

Peroxisomal integrity in demyelination-associated microglia enables cellular debris clearance and myelin renewal in mice

Peroxisomal integrity in demyelination-associated micro...

40

Lineage tracing of pancreatic cells for mechanistic and therapeutic insights

Lineage tracing of pancreatic cells for mechanistic and...

79

Microbiota translocation following intestinal barrier disruption promotes Mincle-mediated training of myeloid progenitors in the bone marrow

Microbiota translocation following intestinal barrier d...

74